未登录

W

Won-Yoon Chung

Yonsei University

H指数:38

被引数:3,918

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1

组织蛋白酶L作为双靶点，在减轻肌肉萎缩的同时增强抗PD-L1的抗肿瘤效果。

Nature Communications

IF15.7

2025-11-280

OAAI

Longitudinal analysis of oral microbiome changes during the neonatal period in full-term and preterm newborns

足月儿和早产儿新生儿期口腔微生物组变化的纵向分析

Journal of Oral Microbiology

IF5.5

2025-09-060

OAAI

Buddlejasaponin IV induces apoptotic cell death by activating the mitochondrial-dependent apoptotic pathway and reducing α2β1 integrin-mediated adhesion in HT-29 human colorectal cancer cells

ONCOLOGY REPORTS

IF3.9

2023-02-105

OA

Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells

BIOMOLECULES & THERAPEUTICS

IF3.2

2022-05-012

OAAI

Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-12-1531

OAAI

CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2019-11-0440

OAAI

Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts

SCIENTIFIC REPORTS

IF3.9

2017-12-1124

OAAI

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis

SCIENTIFIC REPORTS

IF3.9

2017-08-2949

OAAI

Proteome Expression in Human Periodontal Ligament after Delayed Hypothermic Preservation

JOURNAL OF ENDODONTICS

IF3.6

2017-08-015

PREAI

Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer

JOURNAL OF PATHOLOGY

IF5.2

2015-09-2841

OAAI

RUNX3 knockdown inhibited oral cancer-induced bone destruction via reducing TGF-β-dependent responses

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Inhibitory effects of liensinine and nuciferine on breast cancer-associated bone loss

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Stromal transforming growth factor-beta 1 is crucial for reinforcing the invasive potential of low invasive cancer

CANCER RESEARCH

IF16.6

2014-10-010

PRE

The effects of artemisinin, dihydroartemisinin and artemisinin-glycolipid on non-small cell lung cancer induced bone destruction

CANCER RESEARCH

IF16.6

2014-10-011

PRE

Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2014-03-0142

PRE

Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2013-09-0129

PREAI

Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts

INVESTIGATIONAL NEW DRUGS

IF2.7

2013-05-1525

PREAI

The role of RUNX3 and RUNX3-related chemokines in lung cancer-induced bone resorption

CANCER RESEARCH

IF16.6

2013-04-010

PRE

The Inhibitory Effect of Roasted Licorice Extract on Human Metastatic Breast Cancer Cell-Induced Bone Destruction

烤甘草提取物对人转移性乳腺癌细胞诱导的骨破坏的抑制作用

PHYTOTHERAPY RESEARCH

IF6.3

2013-02-1137

PREAI

Characterization of newly established oral squamous cell carcinoma; 33-bp deletion in exons 3-4 of the p53 tumor suppressor gene

IF3.9

2012-11-011

PREAI